Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets and Related Valuation Allowances (Details)

v3.22.1
Schedule of Deferred Tax Assets and Related Valuation Allowances (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Reserves and other $ 179,000 $ 51,000
Net operating loss carry-forwards 23,526,000 21,514,000
Research and development tax credit 610,000 455,000
Share-based compensation 4,021,000 97,000
Valuation Allowance (28,336,000) (22,117,000)
Net deferred tax asset